V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough

Fortrea Holdings Executive Compensation (FY25)

FTRE · Executive and director compensation, fiscal 2023 to 2025

The paid brief on Fortrea Holdings

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$1,500 for the Executive Compensation Report. Both reports for $2,400.
Data as of September 10, 2026Latest filing (8-K): June 12, 2026
6 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Fortrea Holdings brief$1,500Get the executive brief
171 figures on this page: 168 cited to the filing that reported them, 3 calculated from figures it prints. See the citations
Chief executive, fiscal 2025
◇
Anshul Thakral
Latest say-on-pay support
=
June 9, 2026
Chief executive pay ratio
◇
To the median employee

More on Fortrea Holdings

Five data products on this company. Each one is requested through the developer setup page.
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive of record: Thomas Pike → Anshul Thakral
Say-on-pay support: 95.1% → 94.8% (0.3 points lower)
CEO pay ratio: 28:1 → 196:1

Frequently asked questions

Answers drawn from the data on this page.
Who is Fortrea Holdings' chief executive and what were they paid?
Total compensation for Anshul Thakral, Chief Executive Officer and Director, came to $11,584,483 in fiscal 2025.
What was Fortrea Holdings' say-on-pay result?
For fiscal 2025, shareholders backed the say-on-pay proposal with 94.8% of votes cast including abstentions in favor at the meeting held June 9, 2026.
Which companies are in Fortrea Holdings' peer group?
The disclosed peer group names Alkermes plc, Bausch + Lomb Corporation, Bio-Rad Laboratories, Bruker Corporation and Charles River Laboratories International, Inc., among others.
What is Fortrea Holdings' chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 196:1, against median employee compensation of $62,683.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Thomas Pike
Chief Executive Officer
◇—◇◇◇—◇◇
Jill McConnell
Chief Financial Officer
◇◇◇—◇—◇— not reconciled
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Thomas Pike
Chief Executive Officer
◇—◇———◇◇
Jill McConnell
Executive Vice President and Chief Financial Officer
◇—◇———◇— not reconciled
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Anshul Thakral
Chief Executive Officer and Director
◇—◇—◇—◇◇
Thomas Pike
Former Chief Executive Officer
Departed during or after this year
◇—————◇◇
Jill McConnell
Chief Financial Officer
◇—◇—◇—◇◇
Mark Morais
Chief Operating Officer and President, Clinical Services
◇—◇—◇—◇◇
Peter Neupert
Chairman and Former Interim Chief Executive Officer
Departed during or after this year
Served on an interim basis
◇—◇———◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Anshul ThakralRSU◇——◇——◇
Anshul ThakralPSU◇◇◇—◇—◇
Jill McConnellPSU◇◇◇—◇—◇
Jill McConnellRSU◇——◇——◇
Jill McConnellPSU◇◇◇—◇—◇
Jill McConnellRSU◇——◇——◇
Mark MoraisRSU◇——◇——◇
Mark MoraisPSU◇—◇—◇—◇
Mark MoraisPSU◇—◇—◇—◇
Mark MoraisRSU◇——◇——◇
Peter NeupertRSU◇——◇——◇
Thomas PikeRSU◇——◇——◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Mark MoraisRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
Jill McConnellRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
Anshul ThakralPSU◇◇——
RSU◇◇——
Peter NeupertRSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Jill McConnell
Chief Financial Officer · Terms as announced by the company · citing a 2026 filing
Severance multiple◇
Severance cash amount◇
Change-in-control multiple◇
Benefits continuation on change in control◇
Benefits continuation◇
Mark Morais
Chief Operating Officer and President, Clinical Services · Terms as described in the company’s compensation discussion · citing a 2026 filing
Severance multiple◇
Change-in-control multiple◇
Benefits continuation on change in control◇
Benefits continuation◇
Thomas Pike
Former Chief Executive Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
Severance cash amount◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Erin L. Russell
◇◇————◇
Dr. Amrit Ray
◇◇————◇
David Smith
◇◇————◇
Machelle Sanders
◇◇————◇
Edward Pesicka
◇◇————◇
R. Andrew Eckert
◇—————◇
William Sharbaugh
◇—————◇
Peter M. Neupert, Thomas Pike and Anshul Thakral served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Lead independent director premium◇
Audit committee chair◇
Compensation committee chair◇
Compensation committee member◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Alkermes plc ALKS
  • Bausch + Lomb Corporation BLCO
  • Bio-Rad Laboratories BIO
  • Bruker Corporation BRKR
  • Charles River Laboratories International, Inc. CRL
  • CONMED Corporation CNMD
  • DENTSPLY SIRONA Inc. XRAY
  • Enovis Corporation ENOV
  • Exelixis, Inc. EXEL
  • Haemonetics Corporation HAE
  • Integra LifeSciences IART
  • Jazz Pharmaceuticals plc JAZZ
  • Medpace Holdings, Inc. MEDP
  • Organon & Co. OGN
  • Perrigo Company plc PRGO
  • QuidelOrtho Corporation QDEL
  • Sotera Health Company SHC
  • Teleflex Incorporated TFX

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025June 9, 2026=◇◇◇
2024April 17, 2025=◇◇◇
2023May 14, 2024=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Fortrea Holdings files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Fortrea Holdings disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Fortrea Holdings sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Fortrea Holdings' disclosed peer group is defensible, who names Fortrea Holdings back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
171 figures on this page: 168 cited to the filing that reported them, 3 calculated from figures it prints.
168 cited to the filing
3 calculated from the filing

Documents cited

  1. 0001628280-26-042827
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001193125-26-178733
    CEO Pay Ratio · Compensation Discussion and Analysis · Director Compensation · Grants of Plan-Based Awards · and 2 more sections
  3. 0001965040-25-000036
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0001193125-25-100451
    Summary Compensation Table
  5. 0001965040-24-000024
  6. 0001193125-24-080827
    Summary Compensation Table
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Fortrea Holdings executive compensation, FY2023–FY2025.” https://intel.velarion.ai/comp/FTRE (accessed 2026).
Short form: data: Velarion

The paid brief for Fortrea Holdings

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$1,500 for the Executive Compensation Report. Both reports for $2,400.
Get the executive briefGet the board briefNo account needed.
6 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Fortrea Holdings and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

Peers Fortrea Holdings discloses

The companies named in FTRE's own disclosed peer group.

Alkermes plcBausch + Lomb CorporationBio-Rad LaboratoriesBruker CorporationCharles River Laboratories International, Inc.CONMED CorporationDENTSPLY SIRONA Inc.Enovis CorporationExelixis, Inc.Haemonetics CorporationIntegra LifeSciencesJazz Pharmaceuticals plcMedpace Holdings, Inc.Organon & Co.Perrigo Company plcQuidelOrtho CorporationSotera Health CompanyTeleflex Incorporated

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy